Literature DB >> 17344298

La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.

Gjon Blakqori1, Sophie Delhaye, Matthias Habjan, Carol D Blair, Irma Sánchez-Vargas, Ken E Olson, Ghassem Attarzadeh-Yazdi, Rennos Fragkoudis, Alain Kohl, Ulrich Kalinke, Siegfried Weiss, Thomas Michiels, Peter Staeheli, Friedemann Weber.   

Abstract

La Crosse virus (LACV) is a mosquito-transmitted member of the Bunyaviridae family that causes severe encephalitis in children. For the LACV nonstructural protein NSs, previous overexpression studies with mammalian cells had suggested two different functions, namely induction of apoptosis and inhibition of RNA interference (RNAi). Here, we demonstrate that mosquito cells persistently infected with LACV do not undergo apoptosis and mount a specific RNAi response. Recombinant viruses that either express (rLACV) or lack (rLACVdelNSs) the NSs gene similarly persisted and were prone to the RNAi-mediated resistance to superinfection. Furthermore, in mosquito cells overexpressed LACV NSs was unable to inhibit RNAi against Semliki Forest virus. In mammalian cells, however, the rLACVdelNSs mutant virus strongly activated the antiviral type I interferon (IFN) system, whereas rLACV as well as overexpressed NSs suppressed IFN induction. Consequently, rLACVdelNSs was attenuated in IFN-competent mouse embryo fibroblasts and animals but not in systems lacking the type I IFN receptor. In situ analyses of mouse brains demonstrated that wild-type and mutant LACV mainly infect neuronal cells and that NSs is able to suppress IFN induction in the central nervous system. Thus, our data suggest little relevance of the NSs-induced apoptosis or RNAi inhibition for growth or pathogenesis of LACV in the mammalian host and indicate that NSs has no function in the insect vector. Since deletion of the viral NSs gene can be fully complemented by inactivation of the host's IFN system, we propose that the major biological function of NSs is suppression of the mammalian innate immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344298      PMCID: PMC1900204          DOI: 10.1128/JVI.01933-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  A species of small antisense RNA in posttranscriptional gene silencing in plants.

Authors:  A J Hamilton; D C Baulcombe
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

Review 2.  Interferon-producing cells: on the front line in immune responses against pathogens.

Authors:  Marco Colonna; Anne Krug; Marina Cella
Journal:  Curr Opin Immunol       Date:  2002-06       Impact factor: 7.486

Review 3.  La Crosse virus: replication in vertebrate and invertebrate hosts.

Authors:  Monica K Borucki; Brian J Kempf; Bradley J Blitvich; Carol D Blair; Barry J Beaty
Journal:  Microbes Infect       Date:  2002-03       Impact factor: 2.700

Review 4.  Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes.

Authors:  C D Blair; Z N Adelman; K E Olson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 5.  Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity.

Authors:  Otto Haller; Georg Kochs
Journal:  Traffic       Date:  2002-10       Impact factor: 6.215

6.  La Crosse encephalitis in children.

Authors:  J E McJunkin; E C de los Reyes; J E Irazuzta; M J Caceres; R R Khan; L L Minnich; K D Fu; G D Lovett; T Tsai; A Thompson
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

Review 8.  Viral encephalitis: familiar infections and emerging pathogens.

Authors:  Richard J Whitley; John W Gnann
Journal:  Lancet       Date:  2002-02-09       Impact factor: 79.321

Review 9.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

10.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more
  94 in total

1.  Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Authors:  Paul Verbruggen; Marius Ruf; Gjon Blakqori; Anna K Överby; Martin Heidemann; Dirk Eick; Friedemann Weber
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

2.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Genetic characterization of the Wyeomyia group of orthobunyaviruses and their phylogenetic relationships.

Authors:  Rashmi Chowdhary; Craig Street; Amelia Travassos da Rosa; Marcio R T Nunes; Kok Keng Tee; Stephen K Hutchison; Pedro F C Vasconcelos; Robert B Tesh; W Ian Lipkin; Thomas Briese
Journal:  J Gen Virol       Date:  2012-01-25       Impact factor: 3.891

4.  Virus meets RNAi. Symposium on antiviral applications of RNA interference.

Authors:  Ronald P van Rij
Journal:  EMBO Rep       Date:  2008-07-18       Impact factor: 8.807

5.  Gouleako virus isolated from West African mosquitoes constitutes a proposed novel genus in the family Bunyaviridae.

Authors:  M Marklewitz; S Handrick; W Grasse; A Kurth; A Lukashev; C Drosten; H Ellerbrok; F H Leendertz; G Pauli; S Junglen
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

6.  Cell-to-cell spread of the RNA interference response suppresses Semliki Forest virus (SFV) infection of mosquito cell cultures and cannot be antagonized by SFV.

Authors:  Ghassem Attarzadeh-Yazdi; Rennos Fragkoudis; Yi Chi; Ricky W C Siu; Liane Ulper; Gerald Barry; Julio Rodriguez-Andres; Anthony A Nash; Michèle Bouloy; Andres Merits; John K Fazakerley; Alain Kohl
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

Authors:  Michaela Weber; Ali Gawanbacht; Matthias Habjan; Andreas Rang; Christoph Borner; Anna Mareike Schmidt; Sophie Veitinger; Ralf Jacob; Stéphanie Devignot; Georg Kochs; Adolfo García-Sastre; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

8.  Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death.

Authors:  Piyali Mukherjee; Tyson A Woods; Roger A Moore; Karin E Peterson
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

9.  NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.

Authors:  Matthias Habjan; Andreas Pichlmair; Richard M Elliott; Anna K Overby; Timo Glatter; Matthias Gstaiger; Giulio Superti-Furga; Hermann Unger; Friedemann Weber
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  Suppression of RNA interference increases alphavirus replication and virus-associated mortality in Aedes aegypti mosquitoes.

Authors:  Chris M Cirimotich; Jaclyn C Scott; Aaron T Phillips; Brian J Geiss; Ken E Olson
Journal:  BMC Microbiol       Date:  2009-03-05       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.